An act to amend the insurance law to improve access to biomarker testing has reached the governor’s desk. A "biomarker" is a sign of disease, or abnormal function that can be measured in blood, tissue, or body fluid. Biomarker testing examines those elements in search of abnormalities in order to develop a personalized treatment plan. The legislation will require that every state-regulated insurance plan, including Medicaid, provide coverage for biomarker testing when medically appropriate. He stressed he is urging the governor to sign the bill exactly as it was written with no amendments.

Source: Ethiopian News December 16, 2023 01:45 UTC